BBB

Boundless Bio, Inc.

No trades
See on Supercharts
Market capitalization
‪234.85 M‬USD
‪−49.43 M‬USD
‪8.98 M‬
Beta (1Y)

About Boundless Bio, Inc.

CEO
Zachary D. Hornby
Headquarters
San Diego
Employees (FY)
72
Founded
2018
ISIN
US10170A1007
FIGI
BBG00Q4W34T4
Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BOLD is 11.29 USD — it has increased by 6.91% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Boundless Bio, Inc. stocks are traded under the ticker BOLD.
Yes, you can track Boundless Bio, Inc. financials in yearly and quarterly reports right on TradingView.
BOLD stock has fallen by 4.16% compared to the previous week, the month change is a 20.77% fall, over the last year Boundless Bio, Inc. has showed a 20.77% decrease.
BOLD net income for the last quarter is ‪−12.14 M‬ USD, while the quarter before that showed ‪−13.17 M‬ USD of net income which accounts for 7.81% change. Track more Boundless Bio, Inc. financial stats to get the full picture.
No, BOLD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BOLD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Boundless Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
BOLD reached its all-time high on Mar 28, 2024 with the price of 15.24 USD, and its all-time low was 11.20 USD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 72.00 employees. See our rating of the largest employees — is Boundless Bio, Inc. on this list?